Cargando…

Recent Advances and Future Perspective of DC-Based Therapy in NSCLC

Current treatment for patients with non-small-cell lung cancer (NSCLC) is suboptimal since therapy is only effective in a minority of patients and does not always induce a long-lasting response. This highlights the importance of exploring new treatment options. The clinical success of immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Hoorn, Iris A. E., Flórez-Grau, Georgina, van den Heuvel, Michel M., de Vries, I. Jolanda M., Piet, Berber
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273436/ https://www.ncbi.nlm.nih.gov/pubmed/34262573 http://dx.doi.org/10.3389/fimmu.2021.704776

Ejemplares similares

Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
por: Bödder, Johanna, et al.
Publicado: (2021)

Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination
por: van der Woude, Lieke L, et al.
Publicado: (2022)

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
por: Westdorp, Harm, et al.
Publicado: (2021)

Functional Heterogeneity of CD4(+) Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC
por: Oja, Anna E., et al.
Publicado: (2018)

Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites
por: Wefers, Christina, et al.
Publicado: (2019)

STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics
por: de Haas, Nienke, et al.
Publicado: (2019)

What Makes a pDC: Recent Advances in Understanding Plasmacytoid DC Development and Heterogeneity
por: Musumeci, Andrea, et al.
Publicado: (2019)

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets
por: Wimmers, Florian, et al.
Publicado: (2014)

Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2023)

Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go
por: Vasaturo, Angela, et al.
Publicado: (2013)

Human Milk Blocks DC-SIGN–Pathogen Interaction via MUC1
por: Koning, Nathalie, et al.
Publicado: (2015)

Pharmacokinetically‐guided dosing to improve the efficacy of brigatinib in non‐small cell lung cancer patients
por: Koele, Simon E., et al.
Publicado: (2021)

Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity
por: Schetters, Sjoerd T. T., et al.
Publicado: (2018)

Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
por: Jin, Xin, et al.
Publicado: (2022)

Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials
por: Flórez-Grau, Georgina, et al.
Publicado: (2018)

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
por: Veluchamy, John P., et al.
Publicado: (2017)

Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
por: Lv, Meng, et al.
Publicado: (2022)

Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
por: Noubade, Rajkumar, et al.
Publicado: (2019)

Platelets interact with CD169(+) macrophages and cDC1 and enhance liposome-induced CD8(+) T cell responses
por: Grabowska, Joanna, et al.
Publicado: (2023)

Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists
por: Bödder, Johanna, et al.
Publicado: (2023)

Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer
por: Hu, Chunmei, et al.
Publicado: (2023)

Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance
por: Castenmiller, Charlotte, et al.
Publicado: (2021)

TCR Signal Strength Alters T–DC Activation and Interaction Times and Directs the Outcome of Differentiation
por: van Panhuys, Nicholas
Publicado: (2016)

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
por: Groenendijk, Floris H, et al.
Publicado: (2015)

Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion
por: Le Gall, Camille, et al.
Publicado: (2022)

Biologic drugs in the treatment of chronic inflammatory pulmonary diseases: recent developments and future perspectives
por: Plichta, Jacek, et al.
Publicado: (2023)

Augmenting E Protein Activity Impairs cDC2 Differentiation at the Pre-cDC Stage
por: Bajana, Sandra, et al.
Publicado: (2020)

Mild Hypogammaglobulinemia Can Be a Serious Condition
por: Janssen, Lisanne M. A., et al.
Publicado: (2018)

DC-SIGN Mediates the Interaction Between Neutrophils and Leishmania amazonensis-Infected Dendritic Cells to Promote DC Maturation and Parasite Elimination
por: Tiburcio, Rafael, et al.
Publicado: (2021)

Importance of EMT Factor ZEB1 in cDC1 “MutuDC Line” Mediated Induction of Th1 Immune Response
por: Smita, Shuchi, et al.
Publicado: (2018)

Editorial: Immunological challenges around pregnancy complications associated with failures of maternal tolerance to the fetus
por: Eikmans, Michael, et al.
Publicado: (2022)

Phosphatase PTPN22 Regulates Dendritic Cell Homeostasis and cDC2 Dependent T Cell Responses
por: Purvis, Harriet A., et al.
Publicado: (2020)

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
por: Sadozai, Hassan, et al.
Publicado: (2017)

The Consequences of Multiple Simultaneous C-Type Lectin–Ligand Interactions: DCIR Alters the Endo-Lysosomal Routing of DC-SIGN
por: García-Vallejo, Juan J., et al.
Publicado: (2015)

Dendritic Cells Require PINK1-Mediated Phosphorylation of BCKDE1α to Promote Fatty Acid Oxidation for Immune Function
por: Basit, Farhan, et al.
Publicado: (2019)

Strategies to overcome DC dysregulation in the tumor microenvironment
por: Mestrallet, Guillaume, et al.
Publicado: (2022)

Insights on the NF-κB System Using Live Cell Imaging: Recent Developments and Future Perspectives
por: Kizilirmak, Cise, et al.
Publicado: (2022)

Mucosal-associated invariant T cells in patients with axial spondyloarthritis
por: van der Meer, Rienk Gerben, et al.
Publicado: (2023)

MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sjögren's Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1
por: Lopes, Ana P., et al.
Publicado: (2019)

The nature of activatory and tolerogenic dendritic cell-derived signal II
por: Bakdash, Ghaith, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fpdkrpe61aokeflnot9uqllhun